Genes notable for their function
| HUGOSymbol |
Locus |
Gene product |
Associateddisease |
Notes |
Genecard |
| ABO |
|
Glycosyl transferases |
— |
Determinant ofblood type (ABO) |
|
| ALB |
4 |
Serum albumin |
— |
The most abundant protein in human blood plasma |
GeneCardfor ALB |
| BCL2 |
18q21.3 |
Apoptosis regulator Bcl-2 / B-cell CLL/lymphoma 2 |
Several cancers |
The prototype anti-apoptoticprotein |
GeneCardfor BCL2 |
| CCR5 |
3p21 |
chemokine (C-C motif) receptor 5 |
— |
Has an important role in resistance toinfection. |
GeneCardfor CCR5 |
| CD4 |
12pter-p12 |
CD4 antigen |
— |
The prototype marker for T helper cells |
GeneCardfor CD4 |
| CD8 |
2p12 |
CD8 antigen |
— |
The prototype marker forcytotoxic T cells |
GeneCardfor CD8A |
| IL2 |
4q26-q27 |
Interleukin 2 |
Various cancers |
Strong pro-inflammatorycytokine |
GeneCardfor IL2 |
| IL10 |
1q31-q32 |
Interleukin 10 |
— |
anti-inflammatorycytokine |
GeneCardfor IL10 |
Genes that have attracted media attention
| HUGOSymbol |
Locus |
Gene product |
Associateddisease |
Notes |
Genecard |
| BRCA1 |
17q21 |
Breast cancer 1, early onset |
Breast cancer |
Myriad Geneticsowns a controversial patent on this gene [1] |
GeneCardfor BRCA1 |
| BRCA2 |
13q12-13 |
Breast cancer 2, early onset |
Breast cancer |
Myriad Geneticsowns a controversial patent on this gene [2] |
GeneCardfor BRCA2 |
| CD28 |
2q33 |
CD28 antigen |
— |
The target of the immunomodulatory drug TGN1412, which had a dramatic outcome of its first clinical trial in 2006. |
GeneCardfor CD28 |
| NPTN |
15q22 |
Neuroplastin |
— |
A study found that “teenagers who had a highly functioning NPTN gene performed better in intelligence tests”.[3][4][5] |
GeneCardfor NPTN |
| ZBTB7A |
19p13.3 |
Zbtb7 / POK erythroid myeloid ontogenic factor |
Cancer |
Originally calledPOKemon, the gene was renamed after legal threats fromPokémon USA. |
GeneCardforZBTB7A |
Genes causing hereditary diseases
It is the occurrence of an abnormality in these genes that causes the disease.
| HUGOSymbol |
Locus |
Gene product |
Associated disease |
Notes |
Genecard |
| APC |
5q21-q22 |
Adenomatous polyposis coli protein |
Familial adenomatous polyposis |
— |
GeneCardfor APC |
| ASPM |
1q31 |
Abnormal spindle-like microcephaly-associated protein |
Microcephaly |
— |
GeneCardfor ASPM |
| BDNF |
11p13 |
Brain-derived neurotrophic factor |
Congenital central hypoventilation syndrome |
— |
GeneCardfor BDNF |
| CFTR |
7q31.2 |
Cystic fibrosis transmembrane conductance regulator |
Cystic Fibrosis |
One of the first genetic diseases for which gene therapy was believed to be achievable.doi:10.1517/17425247.2.2.269PMID 16296753 |
GeneCardfor CFTR |
| CREBBP |
16p13.3 |
CREB binding protein |
Rubinstein-Taybi syndrome |
— |
GeneCardforCREBBP |
| CRH |
8q13 |
Corticotropinreleasing hormone |
Cushing’s syndrome |
— |
GeneCardfor CRH |
| CXCR4 |
2q21 |
Chemokine (C-X-C motif) receptor 4 / fusin |
WHIM syndrome |
— |
GeneCardfor CXCR4 |
| DHFR |
5q11.2-q13.2 |
Dihydrofolate reductase |
Folate deficiency |
— |
GeneCardfor DHFR |
| HFE |
6p21.3 |
Hereditary hemochromatosis protein precursor |
Haemochromatosis |
— |
GeneCardfor HFE |
| KRT14 |
17q12-q21 |
Keratin |
Epidermolysis bullosa |
— |
GeneCardfor KRT14 |
| KRT5 |
12q13 |
Keratin |
Epidermolysis bullosa |
— |
GeneCardfor KRT5 |
| PGL2 |
11q13.1 |
Paraganglioma or familial glomus tumors 2 |
Paraganglioma |
— |
GeneCardfor PGL2 |
| PHF8 |
Xp11.22 |
PHD finger protein 8 |
Siderius X-linked mental retardation syndrome |
Mutations in the histonedemethylase PHF8 cause cleft lip and palate and mental retardation.doi:10.1093/hmg/ddp480PMID 19843542 |
GeneCardfor PHF8 |
| RHO |
3q21-q24 |
Rhodopsin |
Retinitis pigmentosa |
— |
GeneCardfor RHO |
| SDHB |
1p36.1-p35 |
Succinatedehydrogenasecomplex subunit B |
Pheochromocytoma/Paraganglioma |
— |
GeneCardfor SDHB |
| SDHC |
1q21 |
Succinatedehydrogenasecomplex subunit C |
Pheochromocytoma/Paraganglioma |
— |
GeneCardfor SDHC |
| SDHD |
11q23 |
Succinatedehydrogenasecomplex subunit D |
Pheochromocytoma/Paraganglioma |
— |
GeneCardfor SDHD |
| SRY |
Yp11.3 |
Testis determining factor / Sex determining region Y |
Swyer syndrome / Gonadal dysgenesis / Hermaphroditism |
— |
GeneCardfor SRY |
| TSC1 |
9q34 |
Hamartin |
Tuberous sclerosis |
— |
GeneCardfor TSC1 |
| TSC2 |
16p13.3 |
Tuberin |
Tuberous sclerosis |
— |
GeneCardfor TSC2 |
| MEFV |
16p13.3 |
Pyrin |
Familial Mediterranean Fever |
— |
GeneCardfor MEFV |
| CDH1 |
|
|
|
|
|
Genes contributing to multifactorial diseases
| HUGOSymbol |
Locus |
Gene product |
Associateddisease |
Notes |
Genecard |
| APP |
21q21 |
Amyloid precursor protein |
Alzheimer’s Disease |
— |
GeneCardfor APP |
| GAST |
17q21 |
Gastrin |
Zollinger-Ellison syndrome |
— |
GeneCardfor GAST |
| INS |
11p15.5 |
insulin |
diabetes mellitus |
— |
|
| LCK |
1p35-p34.3 |
Leukocyte-specific protein tyrosine kinase |
Leukemia |
— |
GeneCardfor LCK |
| LEP |
7q31.3 |
Leptin |
Obesity |
— |
GeneCardfor LEP |
| LIF |
22q12.1-q12.2 |
Leukemia inhibitory factor |
Leukemia |
— |
GeneCardfor LIF |
| MCM6 |
2q21 |
Minichromosome maintenance deficient 6 |
lactose intolerance |
— |
GeneCardfor MCM6 |
| MYH7 |
14q12 |
Myosin, heavy polypeptide 7, cardiac muscle, beta |
Hypertrophic cardiomyopathy |
— |
GeneCardfor MYH7 |
| MYOD1 |
11p15.4 |
Myogenic differentiation 1 |
Rhabdomyosarcoma |
— |
GeneCardfor MYOD1 |
| NPPB |
1p36.2 |
Brain Natriuretic Peptide |
Cardiovascular disease |
— |
GeneCardfor NPPB |
| OSM |
22q12.1-q12.2 |
Oncostatin M |
Leukemia |
— |
GeneCardfor OSM |
| PKC |
16p11.2-q12.1 |
Paroxysmal kinesogenic choreoathetosis |
Choreoathetosis |
— |
GeneCardfor PKC |
| PIP |
7q32-q36 |
Prolactin-induced protein |
Fibrocystic breast disease |
— |
GeneCardfor PIP |
| SLC18A2 |
10q25 |
Vesicular Monoamine Transporter |
Drug induced mood disorders |
— |
GeneCardforSLC18A2 |
Leave a Reply